Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew W Segar

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
European Journal of Heart Failure|February 12, 2024
Association of global longitudinal strain by feature tracking cardiac magnetic resonance imaging with adverse outcomes among community-dwelling adults without cardiovascular disease: The Dallas Heart StudyVinayak Subramanian, Neil Keshvani, Matthew W Segar, et al.
Journal of the American Geriatrics Society|May 14, 2025
Frailty Burden and Efficacy of Initial Invasive Strategy in Chronic Coronary Disease: The ISCHEMIA TrialsLajjaben Patel, Matthew W Segar, Muhammad S Usman, et al.
Circulation|December 3, 2021
Diabetes Status Modifies the Association Between Different Measures of Obesity and Heart Failure Risk Among Older Adults: A Pooled Analysis of Community-Based NHLBI CohortsKershaw V Patel, Matthew W Segar, Carl J Lavie, et al.
JACC. Heart Failure|April 1, 2022
Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT TrialMuhammad Shahzeb Khan, Matthew W Segar, Muhammad Shariq Usman, et al.
Diabetologia|March 14, 2021
Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetesMatthew W Segar, Kershaw V Patel, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|September 6, 2024
Development and validation of a machine learning-based approach to identify high-risk diabetic cardiomyopathy phenotypeMatthew W Segar, Muhammad Shariq Usman, Kershaw V Patel, et al.
Diabetes Care|September 15, 2019
Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk ScoreMatthew W Segar, Muthiah Vaduganathan, Kershaw V Patel, et al.
JACC. Heart Failure|August 11, 2023
Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HFMatthew W Segar, Neil Keshvani, Sumitabh Singh, et al.
JACC. Heart Failure|July 28, 2022
Supranormal Left Ventricular Ejection Fraction, Stroke Volume, and Cardiovascular Risk: Findings From Population-Based Cohort StudiesSonia Shah, Matthew W Segar, Nitin Kondamudi, et al.
JAMA Cardiology|July 6, 2022
Machine Learning-Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart FailureMatthew W Segar, Jennifer L Hall, Pardeep S Jhund, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
European Journal of Heart Failure|February 12, 2024
Association of global longitudinal strain by feature tracking cardiac magnetic resonance imaging with adverse outcomes among community-dwelling adults without cardiovascular disease: The Dallas Heart StudyVinayak Subramanian, Neil Keshvani, Matthew W Segar, et al.
Journal of the American Geriatrics Society|May 14, 2025
Frailty Burden and Efficacy of Initial Invasive Strategy in Chronic Coronary Disease: The ISCHEMIA TrialsLajjaben Patel, Matthew W Segar, Muhammad S Usman, et al.
Circulation|December 3, 2021
Diabetes Status Modifies the Association Between Different Measures of Obesity and Heart Failure Risk Among Older Adults: A Pooled Analysis of Community-Based NHLBI CohortsKershaw V Patel, Matthew W Segar, Carl J Lavie, et al.
JACC. Heart Failure|April 1, 2022
Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT TrialMuhammad Shahzeb Khan, Matthew W Segar, Muhammad Shariq Usman, et al.
Diabetologia|March 14, 2021
Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetesMatthew W Segar, Kershaw V Patel, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|September 6, 2024
Development and validation of a machine learning-based approach to identify high-risk diabetic cardiomyopathy phenotypeMatthew W Segar, Muhammad Shariq Usman, Kershaw V Patel, et al.
Diabetes Care|September 15, 2019
Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk ScoreMatthew W Segar, Muthiah Vaduganathan, Kershaw V Patel, et al.
JACC. Heart Failure|August 11, 2023
Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HFMatthew W Segar, Neil Keshvani, Sumitabh Singh, et al.
JACC. Heart Failure|July 28, 2022
Supranormal Left Ventricular Ejection Fraction, Stroke Volume, and Cardiovascular Risk: Findings From Population-Based Cohort StudiesSonia Shah, Matthew W Segar, Nitin Kondamudi, et al.
JAMA Cardiology|July 6, 2022
Machine Learning-Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart FailureMatthew W Segar, Jennifer L Hall, Pardeep S Jhund, et al.
Pageof 7